A mycologist, medical researcher, and entrepreneur, Paul Stamets is considered an intellectual and industry leader in the study of fungi: habitat, medicinal use, and production.

American drug activist and executive who is the founder and former executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Clinical Instructor at University of British Columbia and Adjunct Professor at Vancouver Island University.

Dr. Pamela Kryskow is a medical doctor with a strong interest in psychedelic medicine, mental health and chronic pain.

As a leading attorney in the psychedelics field, Allison advises practitioners, therapists, and religious organizations on the legal, ethical, and regulatory aspects of psychedelic practices, including the Religious Freedom Restoration Act.

Psychiatrist and advocate for integrating psychedelic therapy with traditional psychiatric treatments.

Psychiatrist and author of Good Chemistry, recognized for her work on the effects of psychedelics on mental health.

Co-founder and managing director of Stedde Capital, which invests and consults in plant medicine. Recently, Lasme has shifted focus toward empowering his community through initiatives involving iboga, a psychoactive plant indigenous to Gabon.

Executive Director of the REID. Foundation's American Ibogaine Initiative. During his practice years, he observed the predacious onset of Kentucky’s Opioid Epidemic amid generational joblessness, poverty, disability, and substance use.

Former deputy director of the Drug Policy Research Program at the University of California and current Research Affiliate. Leonard is a public speaker on the history and future of psychedelics, genomic and pharmacological cognitive enhancement, AI in drug development, the fentanyl epidemic, and criminal justice reform.

Psychotherapist dedicated to advancing ethical and effective approaches to ibogaine treatment and harm reduction. A former opioid user, she overcame addiction in 2011 with ibogaine therapy and has since worked to transform how addiction and treatment are approached.

Founder of Psychedelics for Climate Action (PSYCA) and Triple Bottom Why PR. As fractional PR & Brand Director for Nushama, she spearheaded a brand strategy securing 130+ media features for their ketamine therapy for mental health.

She discovered psychedelic-assisted therapy in 2019 and founded “The New Health Club Show” podcast and newsletter, creating a space where people from the new psychedelic ecosystem and businesses could talk about the disruptive power of psychedelics.

Founder of Lucid News, a leading publication dedicated to covering developments in the psychedelic ecosystem with integrity and depth. A veteran journalist and editor, Harrison brings decades of experience in investigative reporting and storytelling.

Managing Partner at JLS Fund, psychedelic investor and general partner. His expertise spans over 30 years in the fields of research, philanthropy, advocacy, policy, criminal justice reform, and the science of psychedelics. He provides valuable guidance to a wide range of organizations, including non-profits, psychedelic and impact startups.

Doctor and co-author for a landmark retrospective study on long-term outcomes from ibogaine treatments. Leading physician in psychedelic-assisted therapies and pioneered the use of ibogaine in the country, completing more than 2,000 treatments and contributing significantly to the regulation of ibogaine in medical settings.

Human Rights Activist and Attorney. She serves as the coordinator and legal counsel for the Ayahuasca Defense Fund under ICEERS, an initiative aimed at protecting the rights of individuals and communities involved with ayahuasca and other sacred plants.

Clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine. Co-led the landmark 2016 clinical trial showing that a single psilocybin session significantly reduces emotional distress in cancer patients. The study demonstrated rapid decreases in depression, anxiety, hopelessness, and demoralization, along with enhanced spiritual well-being and quality of life.